Evidence map›Paper›PMID 42368811›Full record

SynthesisFrontiers in psychiatry2026

Genetic variation associated with depression in Latin American populations: a systematic review of single-nucleotide variants.

Gisela Aguirre, Ana Ramírez, Oscar López-Franco, Rossana C Zepeda, Tania Molina-Jiménez, Armando Jesús Martínez, Claudia Juárez-Portilla, Mónica Flores-Muñoz

Abstract readSystematic Review
In one paragraph

Synthesis in Frontiers in psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Gisela Aguirre *Laboratorio de Neurobiología de la Conducta y Procesos Neuroquímicos, Centro de Investigaciones Biomédicas, Universidad Veracruzana, Xalapa, Veracruz, Mexico.
Ana Ramírez *Laboratorio de Neurobiología de la Conducta y Procesos Neuroquímicos, Centro de Investigaciones Biomédicas, Universidad Veracruzana, Xalapa, Veracruz, Mexico.
Oscar López-FrancoInstituto de Ciencias de la Salud, Universidad Veracruzana, Xalapa, Veracruz, Mexico.
Rossana C ZepedaLaboratorio de Biomedicina Integral y Salud, Centro de Investigaciones Biomédicas, Universidad Veracruzana, Xalapa, Veracruz, Mexico.
Tania Molina-JiménezLaboratorio de Biomedicina Integral y Salud, Centro de Investigaciones Biomédicas, Universidad Veracruzana, Xalapa, Veracruz, Mexico.
Armando Jesús MartínezInstituto de Neuroetología, Universidad Veracruzana, Xalapa, Veracruz, Mexico.
Claudia Juárez-PortillaLaboratorio de Neurobiología de la Conducta y Procesos Neuroquímicos, Centro de Investigaciones Biomédicas, Universidad Veracruzana, Xalapa, Veracruz, Mexico.
Mónica Flores-MuñozInstituto de Ciencias de la Salud, Universidad Veracruzana, Xalapa, Veracruz, Mexico.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Depression is a significant global health burden, with low- and middle-income countries disproportionately affected due to stigma, limited mental health resources, and imprecise diagnosis and treatment. In Latin America, reliance on non-specialized care further contributes to heterogeneous clinical outcomes. Although personalized medicine offers opportunities to improve depression management, genetic research has largely underrepresented Latin American populations, limiting understanding of ancestry-specific risk and treatment response. Methods: This PRISMA 2020-compliant systematic review identified clinical studies assessing single-nucleotide polymorphisms in individuals of Latin American ancestry with depression through searches of PubMed, Web of Science, and EBSCO. Methodological quality was assessed, and findings were synthesized narratively due to substantial heterogeneity across studies. Results: Forty-five studies encompassing 26 cohorts (15 from Mexico, 9 from the United States, 1 from Brazil, and 1 from Peru) reported 306 variants, of which 14 were replicated across at least two independent cohorts. Variants in SLC6A4 (rs25531) and COMT (rs4680) were the most consistently reported. Low-expression rs25531 alleles were uncommon in Mexican and Mexican-American populations but more frequent among individuals with African ancestry. The COMT Met allele was repeatedly associated with greater symptom severity, increased suicide risk, and poorer response to selective serotonin reuptake inhibitors. Additional variants in TPH2, APOE, and BDNF showed ancestry- and context-dependent associations. Discussion: Despite limitations preventing meta-analysis, this review identifies both shared and population-specific genetic factors associated with depression in Latin American populations, highlighting the need for systematic and inclusive psychiatric genetics research to support the development of personalized interventions in underrepresented and resource-limited settings..

Indexed as

ethnicitygenetic susceptibilitymonoaminergic neurotransmissionpersonalized medicineprecision psychiatry

Identifiers

PMID42368811
PMCPMC13307694

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.